Dark Forest Capital Management LP Supernus Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$34.93 - $42.03 $63,328 - $76,200	1,813 New	1,813 $65,000
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $9,270 - $12,535	-366 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$28.51 - $32.9 $10,434 - $12,041	366 New	366 $11,000
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $18,078 - $24,107	-768 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.72 - $33.19 $20,520 - $25,489	768 New	768 $24,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.